Humacyte price target raised to $12 from $6 at H.C. Wainwright
The Fly

Humacyte price target raised to $12 from $6 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Humacyte (HUMA) to $12 from $6 and keeps a Buy rating on the shares. The firm raised its pricing forecast to Humacyte’s Acellular Tissue Engineered Vessel to $50,000 from $25,000.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App